News
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...
UNICEF’s work to improve care for children living with NCDs in Zimbabwe helped Kelly, 10, receive diabetes diagnosis and treatment.
Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...
Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...
Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...
Nova Scotia RCMP say they are continuing to investigate the disappearance of two children from their home in Pictou County, ...
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...
Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...
Lilly Singh joins the Toronto Tempo as co-owner and Chief Hype Officer, bringing her energy to the WNBA's newest team.
The Sam Goodman comeback card has been rocked with a fight day pull out, leaving rising Sydney star Ahmad Reda without an ...
Lilly Singh was announced as the team’s latest addition to its ownership group on Tuesday as well as its “Chief Hype Officer” ...
Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results